Downregulation of NAT1 Expression is Associated with Poor Prognosis and Immune Infiltration in COAD.

Houxi XuHongqun ZhangSongxian SunJingyuan ZhangJie-Ge HuoChunxiang Zhou

Published in: Pharmacogenomics and personalized medicine (2024)

The findings reveal NAT1's potential as a valuable prognostic biomarker for COAD. Moreover, its associated mechanisms offer insights that might pave the way for therapeutic interventions for COAD patients.

Keyphrases

poor prognosis
long non coding rna
end stage renal disease
chronic kidney disease
ejection fraction
newly diagnosed
peritoneal dialysis
physical activity
signaling pathway
cell proliferation
genome wide
patient reported outcomes
dna methylation
human health